Discovery Research Articles

  1. What FDA CRLs Reveal About E&L 2/18/2026

    FDA feedback shows E&L gaps still delay approvals. This preview flags common issues — from unknown compounds to weak tox data — and offers ways to strengthen E&L approaches and cut regulatory risk.

  2. Accelerating CHO Bulk Harvest Testing Requires Rapid Methods 1/14/2026

    Reduce testing timelines from weeks to days with advanced viral detection, as well as achieve faster lot release and regulatory alignment while maintaining safety and compliance for CHO-based processes.

  3. LV Edge System 11/24/2025

    By transitioning from a 4-plasmid transient system to 1- or 0-plasmid configurations, the LV Edge systems reduce or eliminate the need for GMP plasmids, lowering costs and supply chain risks.

  4. What's Next In Pharmaceutical R&D? 11/18/2025

    Emerging R&D trends focus on novel pulmonary and nasal delivery methods. Solubility remains a key challenge, addressed through techniques like microfluidics for nanosuspensions.

  5. Pharma Services Fill, Finish & Drug Delivery CDMO 11/7/2025

    Sterile fill-finish and device assembly capabilities span global sites, offering scalable solutions, analytical testing, and regulatory compliance for combination products and small-batch technical programs.

  6. Driving Rapid Development Of Complex Biologics 11/6/2025

    To meet mAb, bispecific, and multispecific expression needs, sponsors require a proven cell line platform that delivers high‑titer, stable expression for complex proteins.

  7. Discover Our iPSC Differentiated Cell Services 9/30/2025

    iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.

  8. The Essential Role Of High-Quality Anti-Host Cell Protein (HCP) Antibody Reagents 9/13/2025

    Advance biopharmaceutical development with robust HCP detection strategies and high-quality antibody reagents to ensure product purity, safety, and regulatory compliance.

  9. Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod 9/8/2025

    To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.

  10. Decoding The Conformational Plasticity Of Ternary Complexes For Protacs' Differential Activity 9/8/2025

    Leverage our insights into PROTAC ternary complex plasticity and stability to accelerate the design of next-generation therapeutics.